Targeting Metabolism in Cancer Cells and the Tumour Microenvironment for Cancer Therapy

Targeting Metabolism in Cancer Cells and the Tumour Microenvironment for Cancer Therapy

Targeting altered tumour metabolism is an emerging therapeutic strategy for cancer treatment. The metabolic reprogramming that accompanies the development of malignancy creates targetable differences between cancer cells and normal cells, which may be exploited for therapy. There is also emerging ev...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs:	Jiaqi Li, Jie Qing Eu, Li Ren Kong, Lingzhi Wang, Yaw Chyn Lim, Boon Cher Goh, Andrea L. A. Wong
Formaat:	Artikel
Taal:	English
Gepubliceerd in:	MDPI AG 2020-10-01
Reeks:	Molecules
Onderwerpen:	cancer cell metabolism tumour microenvironment metabolic reprogramming targeted therapy immunotherapy
Online toegang:	https://www.mdpi.com/1420-3049/25/20/4831

Gelijkaardige items

Mitochondrial Retrograde Signalling and Metabolic Alterations in the Tumour Microenvironment
door: Dongki Yang, et al.
Gepubliceerd in: (2019-03-01)

Metabolism, metabolites, and macrophages in cancer
door: Mengyuan Li, et al.
Gepubliceerd in: (2023-07-01)

Metabolic reprogramming of the tumor immune microenvironment in ovarian cancer: A novel orientation for immunotherapy
door: Yi Lin, et al.
Gepubliceerd in: (2022-10-01)

Targeting T cell immunometabolism for cancer immunotherapy; understanding the impact of the tumour microenvironment
door: Mary B Mockler, et al.
Gepubliceerd in: (2014-05-01)

Metabolic reprogramming and immune evasion: the interplay in the tumor microenvironment
door: Haixia Zhang, et al.
Gepubliceerd in: (2024-09-01)

Autonomous glucose metabolic reprogramming of tumour cells under hypoxia: opportunities for targeted therapy
door: Mingyao Huang, et al.
Gepubliceerd in: (2020-09-01)

Advances in macrophage and T cell metabolic reprogramming and immunotherapy in the tumor microenvironment
door: Hua Cheng, et al.
Gepubliceerd in: (2024-01-01)

Targeting T cell metabolism in the tumor microenvironment: an anti-cancer therapeutic strategy
door: Zhongping Yin, et al.
Gepubliceerd in: (2019-09-01)

Glucose metabolism and tumour microenvironment in pancreatic cancer: A key link in cancer progression
door: Shi Dong, et al.
Gepubliceerd in: (2022-12-01)

Metabolic reprogramming and crosstalk of cancer-related fibroblasts and immune cells in the tumor microenvironment
door: Yifei Zhu, et al.
Gepubliceerd in: (2022-08-01)

Lighting Up the Fire in the Microenvironment of Cold Tumors: A Major Challenge to Improve Cancer Immunotherapy
door: Alice Benoit, et al.
Gepubliceerd in: (2023-07-01)

Unlocking the potential of T‐cell metabolism reprogramming: Advancing single‐cell approaches for precision immunotherapy in tumour immunity
door: Lihaoyun Huang, et al.
Gepubliceerd in: (2024-03-01)

Analyzing the impact of metabolism on immune cells in tumor microenvironment to promote the development of immunotherapy
door: Yanru Long, et al.
Gepubliceerd in: (2024-01-01)

Targeting cancer-specific metabolic pathways for developing novel cancer therapeutics
door: Soumik Pal, et al.
Gepubliceerd in: (2022-12-01)

Identification of a novel lipid metabolism-related gene signature within the tumour immune microenvironment for breast cancer
door: Xu Chang, et al.
Gepubliceerd in: (2022-05-01)

Metabolic Reprogramming of Thyroid Cancer Cells and Crosstalk in Their Microenvironment
door: Lisha Bao, et al.
Gepubliceerd in: (2021-12-01)

Mechanisms of HIF-driven immunosuppression in tumour microenvironment
door: Shinjini Bandopadhyay, et al.
Gepubliceerd in: (2023-08-01)

The roles of epigallocatechin gallate in the tumor microenvironment, metabolic reprogramming, and immunotherapy
door: Dongming Li, et al.
Gepubliceerd in: (2024-01-01)

Metabolic reprogramming and immunological changes in the microenvironment of esophageal cancer: future directions and prospects
door: Zhi-Xun Guo, et al.
Gepubliceerd in: (2025-01-01)

Targeting lipid metabolism reprogramming of immunocytes in response to the tumor microenvironment stressor: A potential approach for tumor therapy
door: Ming Zhang, et al.
Gepubliceerd in: (2022-09-01)

Glycolysis in the tumor microenvironment: a driver of cancer progression and a promising therapeutic target
door: Junpeng Zhao, et al.
Gepubliceerd in: (2024-06-01)

Fine-Tuning the Tumour Microenvironment: Current Perspectives on the Mechanisms of Tumour Immunosuppression
door: Jesse D. Armitage, et al.
Gepubliceerd in: (2021-01-01)

Effect of neoadjuvant chemotherapy on the immune microenvironment of gynaecological tumours
door: Jing Xue, et al.
Gepubliceerd in: (2023-12-01)

Unveiling the functional roles of patient‐derived tumour organoids in assessing the tumour microenvironment and immunotherapy
door: Di Chen, et al.
Gepubliceerd in: (2024-09-01)

A signature based on circadian rhythm-associated genes for the evaluation of prognosis and the tumour microenvironment in HNSCC
door: Changqian Wang, et al.
Gepubliceerd in: (2024-03-01)

Editorial: Molecular biomarkers and imaging markers in the prediction, diagnosis, and prognosis of bladder cancer
door: Yongwen Luo, et al.
Gepubliceerd in: (2022-10-01)

Advances in reprogramming of energy metabolism in tumor T cells
door: Liu Xuekai, et al.
Gepubliceerd in: (2024-02-01)

Involvement of tumor immune microenvironment metabolic reprogramming in colorectal cancer progression, immune escape, and response to immunotherapy
door: Andrea Nicolini, et al.
Gepubliceerd in: (2024-07-01)

Bicarbonate transport as regulator of antitumour immunity in pancreatic cancer
door: Emily J. Kay, et al.
Gepubliceerd in: (2023-04-01)

Nanomedicines Targeting Metabolism in the Tumor Microenvironment
door: Mengdi Ren, et al.
Gepubliceerd in: (2022-08-01)

Editorial: Tumor metabolic microenvironment: one man’s meat is another man’s poison
door: Jing Xu, et al.
Gepubliceerd in: (2024-05-01)

Targeting tumour microenvironment by tyrosine kinase inhibitor
door: Hor-Yue Tan, et al.
Gepubliceerd in: (2018-02-01)

m6A methylation: a process reshaping the tumour immune microenvironment and regulating immune evasion
door: Xiaoxue Cao, et al.
Gepubliceerd in: (2023-03-01)

Choline metabolism reprogramming mediates an immunosuppressive microenvironment in non-small cell lung cancer (NSCLC) by promoting tumor-associated macrophage functional polarization and endothelial cell proliferation
door: Bijing Xiao, et al.
Gepubliceerd in: (2024-05-01)

High-ammonia microenvironment promotes stemness and metastatic potential in hepatocellular carcinoma through metabolic reprogramming
door: Renchao Zou, et al.
Gepubliceerd in: (2025-02-01)

Editorial: Tumor microenvironment and metabolic reprogramming in cancer
door: Xiaoling Cui, et al.
Gepubliceerd in: (2024-10-01)

Metabolic reprogramming in the tumor microenvironment of liver cancer
door: Jian Lin, et al.
Gepubliceerd in: (2024-01-01)

LncRNAs in tumor metabolic reprogramming and tumor microenvironment remodeling
door: Jianhang Jiao, et al.
Gepubliceerd in: (2024-10-01)

Macrophage metabolic reprogramming and atherosclerotic plaque microenvironment: Fostering each other?
door: Qi Xiao, et al.
Gepubliceerd in: (2023-05-01)

A review of lactate-lactylation in malignancy: its potential in immunotherapy
door: Jinhui Zha, et al.
Gepubliceerd in: (2024-05-01)